Inhibition of hemopoiesis in vitro by neuroblastoma-derived gangliosides

Cancer Research

Volumn 58, Issue 21, 1998, Pages 4840-4844

  Sietsma, Hannie ^a,b   Nijhof, Willem ^b   Dontje, Bert ^b   Vellenga, Edo ^c   Kamps, Willem A ^a   Kok, Jan Willem ^b,c  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

2 DECANOYLAMINO 3 MORPHOLINO 1 PHENYL 1 PROPANOL; ALCOHOL DERIVATIVE; CERAMIDE GLUCOSYLTRANSFERASE; GANGLIOSIDE; SYNTHETASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW SUPPRESSION; COLONY FORMING UNIT GM; CONTROLLED STUDY; ERYTHROPOIESIS; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MOUSE; MYELOPOIESIS; NEUROBLASTOMA CELL; NONHUMAN; PLASMA; PRIORITY JOURNAL;

ANIMALS; FEMALE; G(M3) GANGLIOSIDE; GANGLIOSIDES; HEMATOPOIESIS; HUMANS; MICE; MICE, INBRED C57BL; NEUROBLASTOMA;

EID: 0032213455     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Crist, W. M., and Kun, L. E. Common solid tumors of childhood. N. Engl. J. Med., 324: 461-471, 1991.
2. Niethammer, D., and Handgretinger, R. Clinical strategies for the treatment of neuroblastoma. Eur. J. Cancer, 31A: 568-571, 1995.
3. Ladisch, S., Wu, Z. L., Feig, S., Ulsh, L., Schwartz, E., Floutsis, G., Wiley, F., Lenarsky, C., and Seeger, R. Shedding of GD2 ganglioside by human neuroblastoma. Int. J. Cancer, 39: 73-76, 1987.
4. Kawishima, I., Ozawa, H., Kotani, M., Suzuki, M., Kawano, T., Gomibuchi, M., and Tai, T. Characterisation of ganglioside expression in human melanoma cells: immunological and biochemical analysis. J. Biochem., 114: 186-193, 1993.
5. Merritt, W. D., Der-Minassian, V., and Reaman, G. H. Increased GD3 ganglioside in plasma of children with T-cell acute lymphoblastic leukemia. Leukemia (Baltimore), 8: 816-822, 1994.
6. Anh-Tuan, N., Pick, J., Vajda, J., Harsanyi, V., and Hollan, S. R. Gangliosides in human chronic lymphocytic leukaemia. Int. J. Cancer, 35: 643-646, 1985.
7. Goff, B. A., Lee, W. M., Westrick, M. A., and Macher, B. A. Gangliosides of human chronic lymphocytic leukemia and hairy cells. Eur. J. Biochem., 130: 553-557, 1983.
8. Pick, J., Anh Tuan, N., Mod, A., and Hollan, S. Ganglioside composition in common acute lymphoblastic leukaemia. Haematol. Budap., 19: 33-39, 1986.
9. O'Boyle, K. P., Freeman, K., Kalisiak, A., Agregado, A., and Scheinberg, D. A. Patterns of ganglioside expression in B cell neoplasms. Leuk. Lymphoma, 21: 255-266, 1996.
10. Chang, F. M., Li, R. X., Noon, K., Gage, D., and Ladisch, S. Human medulloblastoma gangliosides. Glycobiology, 7: 523-530, 1997.
11. Marquina, G., Waki, H., Fernandez, L. E., Kon, K., Carr, A., Valiente, O., Perez, R., and Ando, S. Gangliosides expressed in human breast cancer. Cancer Res., 56: 5165-5171, 1996.
12. Ladisch, S. Tumor cell gangliosides. Adv. Pediatr., 34: 45-58, 1987.
13. Dyatlovitskaya, E. V. Sphingolipids and malignant growth. Biochemistry (Engl. Transl. Biokhimiya), 60: 629-633, 1995.
14. Saito, M. Bioactive gangliosides: differentiation inducers for hematopoietic cells and their mechanism(s) of actions. Adv. Lipid Res., 25: 303-327, 1993.
15. Bremer, E. G., Schlessinger, J., and Hakomori, S. Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor. J. Biol. Chem., 261: 2434-2440, 1986.
16. M3 can induce megakaryocytoid differentiation of human leukemia cell line K562 cells. Cancer Res., 51: 1940-1945, 1991.
17. Merzak, A., Koochekpour, S., Mccrea, S., Roxanis, Y., and Pilkington, G. J. Gangliosides modulate proliferation, migration, and invasiveness of human brain tumor cells in vitro. Mol. Chem. Neuropathol., 24: 121-135, 1995.
18. Ladisch, S., Kitada, S., and Hays, E. F. Gangliosides shed by tumor cells enhance tumor formation in mice. J. Clin. Invest., 79: 1879-1882, 1987.
19. Fish, R. G. Role of gangliosides in tumour progression: a molecular target for cancer therapy? Med. Hypotheses, 46: 140-144, 1996.
20. Parker, J., Caldini, G., Krishnamurti, C., Ahrens, P. B., and Ankel, H. Binding of interleukin 2 to gangliosides. FEBS Lett., 170: 391-395, 1984.
21. Bergelson, L. D. Serum gangliosides as endogenous immunomodulators. Immunol. Today, 16: 483-486, 1995.
22. Li, R., Villcreses, N., and Ladisch, S. Human tumor gangliosides inhibit murine immune responses in vivo. Cancer Res., 55: 211-214, 1995.
23. Lu, P., and Sharom, F. J. Gangliosides are potent immunosuppressors of IL-2-mediated T-cell proliferation in a low protein environment. Immunology, 86: 356-363, 1995.
24. Li, R. X., Gage, D., Mckallip, R., and Ladisch, S. Structural characterization and in vivo immunosuppressive activity of neuroblastoma G(D2). Glycoconjugate J., 13: 385-389, 1996.
25. Cabot, M. C., Giuliano, A. E., Volner, A., and Han, T. Y. Tamoxifen retards glycosphingolipid metabolism in human cancer cells. FEBS Lett., 394: 129-131, 1996.
26. Kaucic, K., Grovas, A., Li. R., Quinones, R., and Ladisch, S. Modulation of human myelopoiesis by human gangliosides. Exp. Hematol., 22: 52-59, 1994.
27. Iscove, N. N., and Sieber, F. Erythroid progenitors in mouse bone marrow detected by macroscopic colony formation in culture. Exp. Hematol., 3: 32-43, 1975.
28. Senn, H. J., Orth, M., Fitzke, E., Wieland, H., and Gerok, W. Gangliosides in normal human serum. Concentration, pattern and transport by lipoproteins. Eur. J. Biochem., 181: 657-662, 1989.
29. Ladisch, S., and Gillard, B. A solvent partition method for microscale ganglioside purification. Anal. Biochem., 146: 220-231, 1985.
30. Li, R. X., and Ladisch, S. Abrogation of shedding of immunosuppressive neuroblastoma gangliosides. Cancer Res., 56: 4602-4605, 1996.
31. Usuki, S., Hamanoue, M., Kohsaka, S., and Inokuchi, J. Induction of ganglioside biosynthesis and neunte outgrowth of primary cultured neurons by L-threo-1 -phenyl-2-decanoylamino-3-morpholino-1-propanol. J. Neurochem., 67: 1821-1830, 1996.
32. Inokuchi, J., Mizutani, A., Jimbo, M., Usuki, S., Yamagishi, K., Mochizuki, H., Muramoto, K., Kobayashi, K., Kuroda, Y., Iwasaki, K., Ohgami, Y., and Fujiwara, M. Up-regulation of ganglioside biosynthesis, functional synapse formation, and memory retention by a synthetic ceramide analog (L-PDMP). Stimulation of glycosphingolipid biosynthesis by L-threo-1 -phenyl-2-decanoylamino-1-propanol and its homologs in B16 melanoma cells. Biochem. Biophys. Res. Commun., 117: 766-773, 1995.
33. D2 ganglioside by untreated primary human neuroblastomas. Cancer Res., 46: 440-443, 1986.
34. Uttenreutherfischer, M. M., Huang, C. S., and Yu, A. L. Pharmacokinetics of human-mouse chimeric anti-GD2 mAb ch14.18 in a phase I trial in neuroblastoma patients. Cancer Immunol. Immunother., 41: 331-338, 1995.
35. Ladisch, S., Li. R., and Olson, E. Ceramide structure predicts tumor ganglioside immunosuppressive activity. Proc. Natl. Acad. Sci. USA. 91: 1974-1978, 1994.
36. Riboni, L., Acquotti, D., Casellato, R., Ghidoni, R., Montagnolo, G., Benevento, A., Zecca, L., Rubino, F., and Sonnino, S. Changes of the human liver GM3 ganglioside molecular species during aging. Eur. J. Biochem., 203: 107-113, 1992.